e.g. mhealth
Search Results (1 to 10 of 577 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 170 JMIR Research Protocols
- 124 JMIR Public Health and Surveillance
- 96 JMIR Formative Research
- 85 Journal of Medical Internet Research
- 53 JMIR mHealth and uHealth
- 9 JMIR Serious Games
- 8 JMIR Human Factors
- 6 Iproceedings
- 5 JMIR Mental Health
- 4 JMIR Aging
- 3 Interactive Journal of Medical Research
- 3 JMIR Medical Informatics
- 2 JMIR Medical Education
- 2 JMIR Pediatrics and Parenting
- 2 Online Journal of Public Health Informatics
- 1 JMIR AI
- 1 JMIR Data
- 1 JMIR Dermatology
- 1 JMIR Infodemiology
- 1 Journal of Participatory Medicine
- 0 Medicine 2.0
- 0 iProceedings
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Cardio
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 JMIR XR and Spatial Computing (JMXR)
Additionally, national HIV epidemiology data reported that the ART treatment rate, based on prescription records in Korea, was 95.5%, and the viral suppression rate was 96%, indicating that most people living with HIV belong to the retention in care [4]. While scientific knowledge of “undetectable equals untransmittable (U=U)” has contributed to transforming HIV into a chronic illness, HIV-related discrimination with stigma remains prevalent in health care settings [5].
JMIR Mhealth Uhealth 2025;13:e60905
Download Citation: END BibTex RIS
HIV and viral hepatitis remain large public health challenges in the World Health Organization (WHO) European region. An estimated 3 million people are living with HIV, 10.6 million with hepatitis B, and 8.6 million people with hepatitis C [1-3]. In the European region, the public health burden of HIV and hepatitis B and C is particularly high in the Eastern European and Central Asian countries [4].
HIV and viral hepatitis share similar modes of transmission and coinfections are common [5].
JMIR Res Protoc 2025;14:e62929
Download Citation: END BibTex RIS
The aging global population also includes a growing number of older adults living with HIV [2]. Due to advancements in combination antiretroviral therapy, the life expectancy of people living with HIV has significantly increased [3], leading to the first generation of people living with HIV now reaching geriatric age [4]. This demographic shift brings unique challenges as older adults living with HIV experience a complex interplay of age-related comorbidities and HIV-related health issues [5-7].
JMIR Aging 2025;8:e67122
Download Citation: END BibTex RIS
HIV programs continue in search of effective interventions to increase adherence to antiretroviral therapy (ART), especially for young people living with HIV/AIDS. This group faces increasing rates of new HIV infections [1] and heightened vulnerability to drivers of antiretroviral resistance, such as suboptimal ART adherence [2], ART abandonment, and non-retention in care [3].
JMIR Res Protoc 2025;14:e66941
Download Citation: END BibTex RIS
HIV remains a global public health burden, affecting more than 39 million people living with HIV, with approximately 60% of people living with HIV living in sub-Saharan Africa (SSA) [1,2]. HIV/AIDS has claimed 42.3 million lives since the beginning of the epidemic and 630,000 lives in 2023 alone [1]. In addition, the continuous transmission and heightened rates of new HIV infections across different countries remain a significant concern [1,2].
Interact J Med Res 2025;14:e64829
Download Citation: END BibTex RIS
Stigma Attitudes Toward HIV/AIDS From 2011 Through 2023 in Japan: Retrospective Study in Japan
With the availability of effective antiretroviral treatment, mortality among people with HIV has decreased considerably; in Japan, the 10-year survival rate for people with HIV no longer differs significantly from that for the general population [1]. Further, modern antiretroviral therapy is able to suppress viremia sufficiently to prevent sexual transmission of HIV [2]. Yet, public perception may not necessarily reflect such progress.
J Med Internet Res 2025;27:e69696
Download Citation: END BibTex RIS
This group is a relatively underreached group that continues to experience HIV-related health disparities at a disproportionate rate; approximately 1 in 3 Black sexually minoritized men are estimated to be diagnosed with HIV by age 50 if current rates persist [18,19].
JMIR Public Health Surveill 2025;11:e64497
Download Citation: END BibTex RIS
HIV continues to be a global public health concern, with around 1.3 million new HIV infections occurring in 2022 worldwide [1]. Until 2022, there were around 39 million people living with HIV worldwide. HIV imposes a tremendous health and economic burden on the world. Since the epidemic began, more than 40 million lives have been lost due to HIV-related illnesses [2]. Lifelong antiretroviral treatments require long-term health care services and medications [3].
JMIR Public Health Surveill 2025;11:e59519
Download Citation: END BibTex RIS
HIV remains an important health concern and an area of public health efforts in China, with a particular focus on HIV transmission among gay, bisexual, and other men who have sex with men due to high and sustained risk of HIV infection. A cross-sectional survey of 47,000 men who have sex with men from 61 cities in China in 2008 to 2009 found an overall HIV prevalence of 4.9% [1].
J Med Internet Res 2025;27:e63111
Download Citation: END BibTex RIS
The US HIV epidemic continues to disproportionately impact men who have sex with men (MSM), who comprise 2% of the US population but account for about two-thirds of all new HIV diagnoses in the United States [1]. Epidemic modeling studies [2-4], our National HIV/AIDS Prevention Strategy [5], and the Centers for Disease Control and Prevention (CDC) Ending the HIV Epidemic initiative [6] all emphasize the critical role of pre-exposure prophylaxis (Pr EP) in the national HIV prevention response.
JMIR Res Protoc 2025;14:e56096
Download Citation: END BibTex RIS